Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

World TB Day

World TB Day

World TB Day: improving diagnosis and treatment. Despite being curable, tuberculosis (TB) remains endemic in much of the world. High rates of TB are often found in homeless populations, people in prison, people with drug abuse problems and those with other chronic conditions, such as HIV. Two new drugs have recently been licensed for multi-drug-resistant TB (MDR-TB) but the mainstay of first-line therapy comprises isoniazid, rifampicin, pyrazinamide and ethambutol, all of which can have debilitating side effects. Patients have to take a cocktail of some combination of these drugs for six months, which can lead to difficulties with compliance, especially if they have other, social, issues. World TB Day, held each year on 24 March, aims to raise public awareness of TB and urge governments to take action. This year's theme is 'Unite to end TB'.

Scanning electron micrograph (SEM) of a macrophage engulfing TB bacteria

TB in London: in search of a 21st century approachSubscription

By

London has become the capital of Western Europe for tuberculosis, but an intensive focus on the disease and several new strategies are improving diagnosis and treatment.

More on World TB Day

X-ray showing tuberculosis

Cephalosporins could boost anti-TB therapySubscription

Antimicrobial therapy for tuberculosis (TB) is hampered by the need for long treatment duration and rising prevalence of drug-resistant strains.

Mario Raviglione, director of WHO's global tuberculosis programme

WHO announces cheaper drug treatment for multidrug resistant tuberculosisSubscription

The World Health Organization (WHO) has published new recommendations that seek to speed up detection and enhance cure rates for patients with multidrug resistant tuberculosis (MDR-TB).

Turmeric roots - curcumin is a naturally occurring chemical compound that is found in the spice

Curcumin boosts immune cell power against tuberculosisSubscription

Incubating cells with turmeric compound reduced Mycobacterium tuberculosis infection.

Micrograph of tuberculosis bacteria

Drugs for multidrug-resistant TB are ‘prohibitively expensive’, says MSFSubscription

Just 2% of people with multidrug-resistant tuberculosis have access to drugs that have been on the market for the past two years and which have the potential to save their lives, according to a report by charity Médecins Sans Frontières.

The upper age limit for treating adults with latent tuberculosis (TB) has been increased from 35 years to 65 years in updated guidelines released by NICE. In the image, micrograph of Mycobacterium tuberculosis bacteria

Updated TB guidelines raise upper age limit for treating latent diseaseSubscription

The upper age limit for treating adults with latent tuberculosis (TB) has been increased from 35 years to 65 years in updated guidelines released by the National Institute for Health and Care Excellence.

Pharmaceutical innovation over the past 15 years, coupled with lower prices and improved access to essential medicines, has driven improvements in global health outcomes, says a WHO report. In the image, Margaret Chan, WHO director general

Pharmaceutical innovation continues to drive improvements in global healthSubscription

Over the past 15 years, pharmaceutical innovation, coupled with lower prices and improved access to essential medicines, has driven improvements in global health outcomes, says a World Health Organization report.

Pharmaceutical innovation over the past 15 years, coupled with lower prices and improved access to essential medicines, has driven improvements in global health outcomes, says a WHO report. In the image, Margaret Chan, WHO director general

Serious gaps remain in treatment of multidrug-resistant TB, says WHO reportSubscription

Progress has been made in the global fight against tuberculosis but serious gaps remain in the detection and treatment of the disease, says a World Health Organization report.

Researchers indicate that a modified mycobacterium could be developed as a novel vaccine candidate. In the image, micrograph of mycobacterium tuberculosis

Tuberculosis vaccine candidate outperforms BCG in animal studySubscription

Researchers gave animals a modified version of the tuberculosis bacterium, which helped them fight off infection from disease-causing TB.

Georgia has become the first country to receive free courses of the anti-tuberculosis drug bedaquiline through a partnership between USAID and Janssen Therapeutics. In the image, Mario Raviglione, global TB programme director for the WHO

Janssen provides free courses of anti-TB drug bedaquilineSubscription

Georgia has become the first country to receive free courses of the anti-tuberculosis drug bedaquiline (Sirturo) through an innovative drug donation partnership between USAID and Janssen Therapeutics.

Heart failure treatment Entresto recommended for approval in Europe

Clinical Pharmacist’s monthly news round-up: the top 10 in the past monthSubscription

What’s been happening in the world of pharmacy? Here’s our pick of must-read news from the past month.

More on World TB Day

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.

Pharmaceutical Journal Jobs

More jobs